Merck & Company, Inc. vs Veeva Systems Inc. — Stock Comparison

MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
vs
VEEV
Veeva Systems Inc.
$171.60
▲ 10.02%
Q·Score Winner
Veeva Systems Inc.
VEEV8.9/10vs 6.7/10

Q·Score Breakdown

6.7
Neutral
Overall
8.9
Very Bullish
6.2
Quality
8.5
7
Health
9.7
6.2
Growth
9.5
7.2
Valuation
9.1
7.1
Sentiment
7.6
MRK

Forward P/E of 11.5× is low relative to sector peers.

VEEV

Clean balance sheet with low leverage (0.0× debt-to-equity).

Analyst Consensus

BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $264.46 (+54.1%)
28 analysts

Fundamentals

MRK
VEEV
31.5×
Trailing P/E
31.5×
11.5×
Forward P/E
17.4×
13.6%
Profit Margin
28.4%
76.6%
Gross Margin
75.5%
ROE
13.9%
4.9%
Revenue Growth
16.0%
Earnings Growth
23.2%
0.28
Beta
1.10
Price / Book
$277.0B
Market Cap
$28.2B
$73 – $125
52-Week Range
$148 – $311

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →